HOPIN
23.3.2021 12:32:06 CET | Business Wire | Press release
Hopin , the leading virtual experience platform, announced today that it has acquired video hosting provider Streamable and video technology company Jamm . The technology from both companies will be integrated into Hopin’s current product offering and become the basis for the development of future video products and features. The acquisitions solidify Hopin’s focus to holistically improve its professional-grade video capabilities for organizers that host events on Hopin and to build out its suite of new, video-centric products.
“As the world reopens, high-quality virtual experiences will continue to be critical. Video will be the primary communication channel for businesses, creators and organizations to share experiences virtually, so these acquisitions are a natural next step,” said Johnny Boufarhat, founder and CEO of Hopin. “The technology and resources from Jamm and Streamable will become foundational components to future products and the entire Hopin video experience — from production and video quality to how our customers can collaborate and distribute content.”
Streamable is a popular video hosting site founded by Armen Petrosian in 2014. Petrosian has grown Streamable for the past seven years to become a leading video hosting service that has 75,000 new video uploads per day and over 5,000 paying customers in more than 100 countries. Petrosian will continue to lead Streamable’s business and help build new products at Hopin.
“At Streamable, we’ve always wanted to build products that are simple and easy to use for everyone and we recognized that Hopin’s goal to bring accessibility to events and meetings dovetailed nicely with our own goals,” said Armen Petrosian, founder and CEO of Streamable. “The first priority for Streamable will be to invest in our product suite and ultimately integrate the Streamable platform into Hopin’s future suite of products.”
Jamm was founded in 2019 by Badri Rajasekar to create a lightweight way for users to collaborate over video. Rajasekar is an expert in video technology and was previously CTO of the real-time communication API platform TokBox prior to Jamm. TokBox was acquired by Telefonica in 2012 and subsequently spun out to Vonage in 2018. Jamm hosts a number of customers including Swoop, SignEasy, Deepsource, Stackery and others across a range of industry verticals such as fintech, gaming, education and more. Rajasekar will play a key role in helping develop new features and products in-house at Hopin.
“Since I founded Jamm in 2019, we’ve seen growing interest as more businesses pursue a remote-work strategy. I’ve witnessed firsthand how productive remote teams can become when they have a video solution that’s lightweight and collaborative,” said Jamm founder and CEO Badri Rajasekar. “I’m excited to bring my expertise to Hopin and build upon the great products Johnny has already developed, to make virtual experiences even easier for Hopin customers.”
Hopin continues to see impressive demand for its products and services. In a little over a year, Hopin has grown to millions of users and more than 90,000 organizers hosting events. The two acquisitions are a continuation of Hopin’s rapid growth, as it looks to its future product roadmap to drive and meet the demand of current and future customers. Hopin recently acquired mobile app development company Topi and video streaming company StreamYard, adding StreamYard’s 3.6 million video content creators to its base. Hopin has also raised $570M to-date, with its most recent raise a $400M Series C earlier this month, co-led by Andreessen Horowitz and General Catalyst.
About Hopin
Founded in 2019, Hopin enables brands and communities to create all-in-one live video experiences for their audiences. Through its platforms, attendees can learn, interact, and connect with people from anywhere in the world. With Hopin, you can create live virtual and hybrid events that are interactive and immersive. Hopin acquired StreamYard, a leading video streaming studio, in 2020. Hopin is a remote-first company headquartered in London, with employees in 42 countries. Learn more at hopin.com.
About Streamable
Streamable is an internet video streaming company that powers innovative video experiences for thousands of creators and businesses all around the world. With Streamable, you can upload, crop, trim, embed and share videos — all without ever leaving your browser. Whether you’re just getting started or you have advanced video hosting and editing needs, Streamable is perfect for you. Get started today at https://streamable.com .
About Jamm
Jamm is a virtual workplace application that enables lightweight voice and video collaboration for remote teams. Jamm aims to unlock more spontaneous connections and short bursty conversations in the workplace. With powerful collaboration features like screen-sharing, white-boarding, recorded video stories and more — unlock your team’s full potential with Jamm. Try it out now at https://jamm.app .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210323005439/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
WHOOP Expands Commitment to Women's Health by Including One-Year Subscription of Natural Cycles° App in Membership4.8.2026 11:00:00 CEST | Press release
The integration gives eligible WHOOP members seamless access to the only FDA-cleared hormone-free birth control app, with the first year of Natural Cycles° included for those new to the app as part of their WHOOP membership. WHOOP, the human performance company, today announced an expansion of its women’s health offering through an integration with Natural Cycles° (NC°), the only FDA-cleared, hormone-free birth control app. WHOOP is offering a 12-month subscription to the NC° app to eligible new Natural Cycles users. Members with compatible WHOOP devices can now automatically share overnight skin temperature with the NC° app to enable personalized fertility insights and hormone-free birth control. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260804399367/en/ WHOOP Expands Commitment to Women's Health by Including One-Year Subscription of Natural Cycles° App in Membership The Natural Cycles app, a Class II medical device, u
Alphatax Makes Two Acquisitions to Strengthen Transfer Pricing Capabilities4.8.2026 10:00:00 CEST | Press release
Acquisitions Expand Transfer Pricing Offering and Support Long-Term Platform Strategy Alphatax, the global tax compliance software provider, has today announced the acquisitions of TP Accurate and Intra Pricing Solutions, expanding its transfer pricing capabilities and reinforcing its ambition to build the world's first tax operating system. The acquisitions strengthen Alphatax's transfer pricing portfolio with complementary capabilities across financial transactions and documentation. TP Accurate provides specialist software for intra-group financing arrangements, while Intra Pricing Solutions' flagship product, TPGenie, enables multinational organisations and advisors to produce transfer pricing documentation using intelligent automation and AI. Together, they expand Alphatax's ability to support the full transfer pricing lifecycle, helping customers manage compliance more efficiently while improving governance and reducing audit risk. They also represent another step towards Alphata
LabPMM® Launches Global KMT2A MRD Testing Service to Support Menin Inhibitor Development and Acute Leukemia Care4.8.2026 09:10:00 CEST | Press release
LabPMM®, an Invivoscribe® subsidiary, today announced the global availability of its new KMT2A measurable residual disease (MRD) testing service. The highly sensitive digital PCR service is available to healthcare providers, clinical researchers, and biopharmaceutical partners through LabPMM’s global laboratory network, with CAP/CLIA-accredited testing available in the U.S. The service addresses a growing need for accurate molecular monitoring in acute leukemias.1,2,3 KMT2A rearrangements (KMT2Ar) are oncogenic drivers in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).4 These rearrangements are present in about 80% of infant cases and 5-15% of childhood and adult leukemia cases.5 KMT2Ar leukemias are associated with chemotherapy resistance, high relapse rates, and poor clinical outcomes.5 The emergence of menin inhibitors is transforming the therapeutic landscape for patients with AML and ALL, particularly those with KMT2A-rearranged and NPM1-mutated disease.6 The
“HATSUNE MIKU LIGHTS TOKYO” Debuts on July 254.8.2026 09:00:00 CEST | Press release
Giant Hatsune Miku Returns to Light Up Tokyo’s Night! The Tokyo Metropolitan Government has been presenting year-round projection mapping displays on the Tokyo Metropolitan Government Building, using light and sound to showcase a wide range of artistic expressions as part of its efforts to create new nighttime tourism attractions in Tokyo. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260802298570/en/ © Crypton Future Media, INC. On Saturday, July 25, "HATSUNE MIKU LIGHTS TOKYO", featuring the globally beloved virtual singer Hatsune Miku, held its first screening. The work brings the world of the popular song “M@GICAL☆CURE! LOVE ♥ SHOT!” to life across the entire façade of the Tokyo Metropolitan Government Building. Since its launch in February 2024, “TOKYO Night & Light” has welcomed visitors from Japan and around the world, with total attendance surpassing 1.55 million. As one of Tokyo’s emerging landmark attractions, the
Mosaic Therapeutics appoints Dr Allison Jeynes as Chair of the Board4.8.2026 09:00:00 CEST | Press release
Accomplished life sciences leader with a proven track record of driving successful development of novel therapeutics, joins Mosaic to guide its next phase of growthAllison brings three decades of drug development, board and executive leadership experience to support Mosaic’s transition towards a clinical-stage company Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) an oncology therapeutics company developing novel, targeted drug combinations across a range of haematological and solid cancers, today announced the appointment of Dr Allison Jeynes as Chair of the Board to support its next phase of growth and advancement towards clinical development. Allison succeeds Dr Edward Hodgkin, who remains a Non-Executive Director of the Board. Allison is a UK-trained oncologist and highly-experienced life sciences leader, and brings over three decades of drug development and executive experience to Mosaic Therapeutics. As CEO of Avillion, a clinical development company, for the last 13 year
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom